Liu Y, Yang Q (2023) The roles of EZH2 in cancer and its inhibitors. Med Oncol 40:167. https://doi.org/10.1007/s12032-023-02025-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan R, Du W, Guo W (2020) EZH2: a novel target for cancer treatment. J Hematol Oncol 13:104. https://doi.org/10.1186/s13045-020-00937-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Zhang J, Guo Z et al (2021) Easy or not-the advances of EZH2 in regulating T cell development, differentiation, and activation in antitumor immunity. Front Immunol 12:741302. https://doi.org/10.3389/fimmu.2021.741302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Settipane RA (2009) Epidemiology of vasomotor rhinitis. World Allergy Organ J 2:115–118. https://doi.org/10.1097/WOX.0b013e3181ac91ae

Article  PubMed  PubMed Central  Google Scholar 

Keith PK, Desrosiers M, Laister T et al (2012) The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allerg Asthma Clin Immunol 8:7. https://doi.org/10.1186/1710-1492-8-7

Article  Google Scholar 

McCrory DC, Williams JW, Dolor RJ, et al (2003) Management of allergic rhinitis in the working-age population. Evid Rep Technol Assess (Summ) 1–4.

Licari A, Magri P, De Silvestri A et al (2023) Epidemiology of allergic rhinitis in children: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 11:2547–2556. https://doi.org/10.1016/j.jaip.2023.05.016

Article  PubMed  Google Scholar 

Yan CH, Hwang PH (2018) Surgical management of nonallergic rhinitis. Otolaryngol Clin North Am 51:945–955. https://doi.org/10.1016/j.otc.2018.05.010

Article  PubMed  Google Scholar 

Hastan D, Fokkens WJ, Bachert C et al (2011) Chronic rhinosinusitis in Europe–an underestimated disease. A GA2LEN study. Allergy 66:1216–1223. https://doi.org/10.1111/j.1398-9995.2011.02646.x

Article  CAS  PubMed  Google Scholar 

Blackwell DL, Lucas JW, Clarke TC (2014) Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10:1–161

Google Scholar 

Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34:877–885. https://doi.org/10.1002/hed.21830

Article  PubMed  Google Scholar 

Cao R, Zhang Y (2004) The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14:155–164. https://doi.org/10.1016/j.gde.2004.02.001

Article  CAS  PubMed  Google Scholar 

Rea S, Eisenhaber F, O’Carroll N et al (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406:593–599. https://doi.org/10.1038/35020506

Article  CAS  PubMed  Google Scholar 

Varambally S, Dhanasekaran SM, Zhou M et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624–629. https://doi.org/10.1038/nature01075

Article  CAS  PubMed  Google Scholar 

Bachmann IM, Halvorsen OJ, Collett K et al (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24:268–273. https://doi.org/10.1200/JCO.2005.01.5180

Article  CAS  PubMed  Google Scholar 

Chang CJ, Yang JY, Xia W et al (2011) EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 19:86–100. https://doi.org/10.1016/j.ccr.2010.10.035

Article  CAS  PubMed  PubMed Central  Google Scholar 

He A, Shen X, Ma Q et al (2012) PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev 26:37–42. https://doi.org/10.1101/gad.173930.111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim E, Kim M, Woo DH et al (2013) Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 23:839–852. https://doi.org/10.1016/j.ccr.2013.04.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Troselj KG, Kujundzic RN, Ugarkovic D (2016) Polycomb repressive complex’s evolutionary conserved function: the role of EZH2 status and cellular background. Clin Epigenetics 8:55. https://doi.org/10.1186/s13148-016-0226-1

Article  CAS  Google Scholar 

Lee JM, Lee JS, Kim H et al (2012) EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell 48:572–586. https://doi.org/10.1016/j.molcel.2012.09.004

Article  CAS  PubMed  Google Scholar 

Vasanthakumar A, Xu D, Lun ATL et al (2017) A non-canonical function of Ezh2 preserves immune homeostasis. EMBO Rep 18:619–631. https://doi.org/10.15252/embr.201643237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loh JT, Lim TJF, Ikumi K et al (2018) Ezh2 controls skin tolerance through distinct mechanisms in different subsets of skin dendritic cells. iScience 10:23–39. https://doi.org/10.1016/j.isci.2018.11.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi B, Liang J, Yang X et al (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 27:5105–5119. https://doi.org/10.1128/MCB.00162-07

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu K, Wu ZJ, Groner AC et al (2012) EZH2 oncogenic activity in castration-resistant prostate cancer cells is polycomb-independent. Science 338:1465–1469. https://doi.org/10.1126/science.1227604

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez ME, Moore HM, Li X et al (2014) EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc Natl Acad Sci U S A 111:3098–3103. https://doi.org/10.1073/pnas.1308953111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee ST, Li Z, Wu Z et al (2011) Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. Mol Cell 43:798–810. https://doi.org/10.1016/j.molcel.2011.08.011

Article  CAS  PubMed  Google Scholar 

Tong Q, He S, Xie F et al (2014) Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice. J Immunol 192:5012–5022. https://doi.org/10.4049/jimmunol.1302943

Article  CAS  PubMed  Google Scholar 

Tumes DJ, Onodera A, Suzuki A et al (2013) The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. Immunity 39:819–832. https://doi.org/10.1016/j.immuni.2013.09.012

Article  CAS  PubMed  Google Scholar 

Zhang Y, Kinkel S, Maksimovic J et al (2014) The polycomb repressive complex 2 governs life and death of peripheral T cells. Blood 124:737–749. https://doi.org/10.1182/blood-2013-12-544106

Article  CAS  PubMed  Google Scholar 

Li F, Zeng Z, Xing S et al (2018) Ezh2 programs TFH differentiation by integ